Canine joint injections gain attention in OA management
Therapeutic joint injections are getting a closer look in canine osteoarthritis care, with Clinician’s Brief spotlighting the topic in a May 2026 podcast featuring Margret Lenfest, VMD, DACVSMR, CVA, of Cornell University. In the discussion, Lenfest describes intra-articular therapy as a way to deliver treatment directly to the affected joint and potentially reduce reliance on systemic drugs such as NSAIDs. The episode highlights three commonly used injectates, triamcinolone, hyaluronic acid, and platelet-rich plasma, and emphasizes that earlier use may produce better outcomes, with the goal of several months of benefit after injection. Contraindications discussed include infected joints, immune-mediated joint disease, cancer, poor skin suitability for sterile needle passage, and patients that may not tolerate sedation. (cliniciansbrief.com)
Why it matters: For veterinary professionals, the renewed attention reflects a broader shift toward multimodal, joint-targeted osteoarthritis management in dogs. Clinician’s Brief’s related December 2025 review notes that therapeutic joint injection can help concentrate medication at the source of disease, potentially limiting systemic adverse effects, but it also underscores important caveats: evidence in dogs remains limited for some injectates, complication risks include transient pain, joint flare, and septic arthritis, and imaging guidance is recommended when possible because landmark-guided injections can be inaccurate, especially in deeper joints. Consensus guidance published in Frontiers in Veterinary Science says PRP currently has the strongest canine evidence among joint injectates, while also noting that protocol variability and limited standardization still make definitive recommendations difficult. (cliniciansbrief.com)
What to watch: Expect continued interest in training, ultrasound-guided technique, and better-standardized canine studies that clarify which patients, products, and protocols deliver the most durable benefit. (cliniciansbrief.com)